These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 33169635)

  • 1. Direct nose to brain delivery of small molecules: critical analysis of data from a standardized
    Dhuyvetter D; Tekle F; Nazarov M; Vreeken RJ; Borghys H; Rombouts F; Lenaerts I; Bottelbergs A
    Drug Deliv; 2020 Dec; 27(1):1597-1607. PubMed ID: 33169635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct nose to brain drug delivery via integrated nerve pathways bypassing the blood-brain barrier: an excellent platform for brain targeting.
    Pardeshi CV; Belgamwar VS
    Expert Opin Drug Deliv; 2013 Jul; 10(7):957-72. PubMed ID: 23586809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent patents review on intranasal administration for CNS drug delivery.
    Jogani V; Jinturkar K; Vyas T; Misra A
    Recent Pat Drug Deliv Formul; 2008; 2(1):25-40. PubMed ID: 19075895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanoemulsion-based intranasal drug delivery system of saquinavir mesylate for brain targeting.
    Mahajan HS; Mahajan MS; Nerkar PP; Agrawal A
    Drug Deliv; 2014 Mar; 21(2):148-54. PubMed ID: 24128122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can nasal drug delivery bypass the blood-brain barrier?: questioning the direct transport theory.
    Merkus FW; van den Berg MP
    Drugs R D; 2007; 8(3):133-44. PubMed ID: 17472409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From nose to brain: understanding transport capacity and transport rate of drugs.
    Wu H; Hu K; Jiang X
    Expert Opin Drug Deliv; 2008 Oct; 5(10):1159-68. PubMed ID: 18817519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct nose-brain transport of benzoylecgonine following intranasal administration in rats.
    Chow HH; Anavy N; Villalobos A
    J Pharm Sci; 2001 Nov; 90(11):1729-35. PubMed ID: 11745730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanoparticle transport across in vitro olfactory cell monolayers.
    Gartziandia O; Egusquiaguirre SP; Bianco J; Pedraz JL; Igartua M; Hernandez RM; Préat V; Beloqui A
    Int J Pharm; 2016 Feb; 499(1-2):81-89. PubMed ID: 26721725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nose-to-brain drug delivery: An update on clinical challenges and progress towards approval of anti-Alzheimer drugs.
    Agrawal M; Saraf S; Saraf S; Antimisiaris SG; Chougule MB; Shoyele SA; Alexander A
    J Control Release; 2018 Jul; 281():139-177. PubMed ID: 29772289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoneurotherapeutics approach intended for direct nose to brain delivery.
    Md S; Mustafa G; Baboota S; Ali J
    Drug Dev Ind Pharm; 2015; 41(12):1922-34. PubMed ID: 26057769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Versatile Nanoparticulate Systems as a Prosperous Platform for Targeted Nose-Brain Drug Delivery.
    Taha E; Shetta A; Nour SA; Naguib MJ; Mamdouh W
    Mol Pharm; 2024 Mar; 21(3):999-1014. PubMed ID: 38329097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of brain targeting and mucosal integrity of nasally administrated nanostructured carriers of a CNS active drug, clonazepam.
    Abdel-Bar HM; Abdel-Reheem AY; Awad GA; Mortada ND
    J Pharm Pharm Sci; 2013; 16(3):456-69. PubMed ID: 24021293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A microdialysis model to examine nasal drug delivery and olfactory absorption in rats using lidocaine hydrochloride as a model drug.
    Bagger M; Bechgaard E
    Int J Pharm; 2004 Jan; 269(2):311-22. PubMed ID: 14706243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nose-to-brain drug delivery for the treatment of CNS disease: New development and strategies.
    Du L; Chen L; Liu F; Wang W; Huang H
    Int Rev Neurobiol; 2023; 171():255-297. PubMed ID: 37783558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Nose-to-Brain Delivery of Peptide Drugs Enhanced by Coadministration of Cell-penetrating Peptides: Therapeutic Potential for Dementia].
    Kamei N
    Yakugaku Zasshi; 2017; 137(10):1247-1253. PubMed ID: 28966266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formulation and In-vivo Pharmacokinetic Consideration of Intranasal Microemulsion and Mucoadhesive Microemulsion of Rivastigmine for Brain Targeting.
    Shah B; Khunt D; Misra M; Padh H
    Pharm Res; 2018 Jan; 35(1):8. PubMed ID: 29294189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanosized Drug Delivery Systems for Direct Nose to Brain Targeting: A Review.
    Phukan K; Nandy M; Sharma RB; Sharma HK
    Recent Pat Drug Deliv Formul; 2016; 10(2):156-64. PubMed ID: 26996366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Cerebrospinal Fluid Circulation on Nose-to-Brain Direct Delivery and Distribution of Caffeine in Rats.
    Inoue D; Furubayashi T; Tanaka A; Sakane T; Sugano K
    Mol Pharm; 2020 Nov; 17(11):4067-4076. PubMed ID: 32955898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights into direct nose to brain delivery: current status and future perspective.
    Mittal D; Ali A; Md S; Baboota S; Sahni JK; Ali J
    Drug Deliv; 2014 Mar; 21(2):75-86. PubMed ID: 24102636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct Drug Delivery of Low-Permeable Compounds to the Central Nervous System Via Intranasal Administration in Rats and Monkeys.
    Iwasaki S; Yamamoto S; Sano N; Tohyama K; Kosugi Y; Furuta A; Hamada T; Igari T; Fujioka Y; Hirabayashi H; Amano N
    Pharm Res; 2019 Apr; 36(5):76. PubMed ID: 30937626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.